Altasciences Executive and Leadership Team

Marie-Helene Raigneau, the Chief Executive Officer at Altasciences, directs the overarching strategic vision and operational execution for the contract research organization. Raigneau's leadership focuses on enhancing the company's integrated preclinical and clinical services, ensuring seamless delivery of bioanalytical and CRO solutions to clients. Overseeing global operations, Raigneau drives innovation in service offerings and fosters a culture of scientific excellence. This executive role involves aligning departmental objectives with the company's mission to accelerate drug development timelines for pharmaceutical and biotechnology partners. By optimizing resource allocation and strategic partnerships, Marie-Helene Raigneau ensures Altasciences maintains its competitive edge in the research services sector, contributing directly to the company's sustained growth and market impact.

Christopher Perkin, the President & Chief Executive Officer at Altasciences, spearheads the company's strategic direction and global expansion initiatives. Perkin's leadership is central to driving the integration of preclinical, clinical, manufacturing, and analytical services, ensuring a cohesive client experience. Overseeing all facets of the organization, Christopher Perkin champions operational efficiency and scientific integrity across all service lines, including bioanalytical and CRO functions. This executive position involves cultivating key stakeholder relationships and steering the company's growth trajectory within the competitive contract research landscape. By focusing on innovation and client-centric solutions, Perkin ensures Altasciences consistently delivers high-quality research support, directly impacting the successful advancement of client drug development programs.

Robert Sabelli, the Co-Chief Operating Officer at Altasciences, manages critical operational functions that underpin the company's comprehensive service delivery. Sabelli's responsibilities encompass optimizing internal processes for preclinical and clinical research, ensuring efficient execution of manufacturing and analytical services. This leadership role involves driving operational excellence across bioanalytical and CRO departments, enhancing productivity and resource utilization. By focusing on streamlining workflows and implementing best practices, Robert Sabelli directly supports the company's ability to meet client timelines and quality standards. This executive's strategic oversight ensures the seamless integration of diverse service offerings, contributing significantly to Altasciences' reputation for reliability and scientific rigor in the contract research sector.

Steve Mason, the Co-Chief Operating Officer at Altasciences, oversees key operational aspects that ensure the efficient and effective delivery of contract research services. Mason's responsibilities include managing the integration of manufacturing and analytical services with preclinical and clinical operations, driving operational synergy. This executive role focuses on enhancing supply chain logistics and resource management across the organization, supporting bioanalytical and CRO functions. By implementing robust operational frameworks, Steve Mason directly contributes to Altasciences' capacity to handle complex projects and maintain high levels of client satisfaction. Mason's operational leadership ensures the company's infrastructure supports its growth and commitment to scientific excellence.

Charles Spainhour, the President and CSO at Altasciences, directs the scientific strategy and research initiatives that define the company's service portfolio. Spainhour's expertise is crucial in advancing the preclinical and clinical capabilities, ensuring the highest standards of scientific rigor in bioanalytical and CRO services. This executive role involves guiding research methodologies and fostering innovation across all scientific disciplines. By championing cutting-edge research approaches, Charles Spainhour enhances Altasciences' capacity to support complex drug development projects. Spainhour's strategic vision ensures the company remains at the forefront of scientific discovery, directly contributing to the successful outcomes for clients seeking to bring novel therapeutics to market.

Nicole Maciolek, the Executive Vice President & Chief Revenue Officer, Services at Altasciences, drives the commercial strategy and revenue growth for the company's extensive service offerings. Maciolek's leadership focuses on expanding market reach for preclinical and clinical services, manufacturing, and analytical support. This executive role involves cultivating strategic client partnerships and identifying new business opportunities within the bioanalytical and CRO sectors. By optimizing sales processes and enhancing client engagement, Nicole Maciolek ensures Altasciences consistently meets and exceeds revenue targets. Maciolek's commercial acumen directly contributes to the company's sustained financial performance and its ability to invest in further service innovation and expansion.

Gaetano Morelli, the Chief Medical Officer at Altasciences, provides critical medical and scientific oversight for the company's clinical research services. Morelli's expertise guides the design and execution of clinical trials, ensuring patient safety and data integrity throughout the development process. This executive role involves interpreting complex medical data and advising on therapeutic area strategies for preclinical and clinical projects. By leveraging extensive medical knowledge, Gaetano Morelli enhances the scientific credibility of Altasciences' offerings, particularly in bioanalytical and CRO services. Morelli's leadership ensures that clinical research conducted by the company adheres to the highest ethical and regulatory standards, directly supporting client success in drug development.

Catherine Konidas, the Chief Administrative Officer at Altasciences, manages essential administrative functions that support the company's operational efficiency and strategic objectives. Konidas oversees human resources, legal affairs, and corporate governance, ensuring compliance and fostering a productive work environment. This executive role is vital for integrating administrative support across all departments, including preclinical, clinical, manufacturing, and analytical services. By optimizing internal processes and resource management, Catherine Konidas directly contributes to the smooth functioning of Altasciences. Konidas's administrative leadership ensures the company operates effectively, allowing scientific and commercial teams to focus on delivering exceptional CRO and bioanalytical services.

Joel Woods, the Senior Director, Information Technology & Strategic Planning at Altasciences, directs the company's technology infrastructure and long-term strategic technology initiatives. Woods oversees the implementation and maintenance of IT systems that support all operational areas, including preclinical and clinical research, manufacturing, and analytical services. This leadership role is critical for ensuring data security, system reliability, and the adoption of innovative technologies within the bioanalytical and CRO functions. By aligning IT strategy with business goals, Joel Woods enhances operational efficiency and supports data-driven decision-making across the organization. Woods's strategic planning ensures Altasciences leverages technology effectively to drive growth and maintain a competitive advantage.